| [1] |
Ni MC,Rodgers A,Pan W H, et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants[J]. Int J Epidemiol, 2004, 33(4):751-758.
|
| [2] |
Bergstrom A,Pisani P,Tenet V. Overweight as an avoidable cause of cancer in Europe[J]. International Journal of Cancer, 2001, 92(6):421-430.
|
| [3] |
Harvie M,Hooper L,Howell AH. Central obesity and breast cancer risk: a systematic review[J]. Obes Reviews, 2003, 4(3):157-173.
|
| [4] |
Flegal KM,Kit BK,Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis[J]. JAMA,2013, 309(1):71-82.
|
| [5] |
Mokdad AH,Ford ES,Bowman BA, et al.Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001[J]. JAMA, 2003, 289(1):76-79.
|
| [6] |
Melissas J. IFSO guidelines for safety, quality, and excellence in bariatric surgery[J]. Obes Surgery, 2008, 18(5):497-500.
|
| [7] |
Finkelstein EA,Brown DS,Wrage LA, et al. Individual and aggregate years-of-life-lost associated with overweight and obesity[J]. Obesity, 2010, 18(2):333-339.
|
| [8] |
Hubbard VS,Hall WH. Gastrointestinal Surgery for Severe Obesity[J].Obes Surg, 1991, 1(3):257-265.
|
| [9] |
Dixon JB,Zimmet P,Alberti KG, et a1. Bariatric surgery:an IDF statement for obese Type 2 diabetes[J]. Arquivos Brasileiros De Endocrinologia E Metabologia, 2011, 28(6):628-642.
|
| [10] |
Rubino F,Nathan DM,Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations[J]. Diabetes Care, 2016, 39(11):1-20.
|
| [11] |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖和2型糖尿病外科治疗指南(2014)[J].中国实用外科杂志, 2014, 34(11):1005-1010.
|
| [12] |
Association AD. Obesity Management for the Treatment of Type 2 Diabetes.[J]. Diabetes Care, 2016, 39(Suppl.1):S47-S51.
|
| [13] |
Marathe PH,Gao HX,Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017[J]. Journal of Diabetes, 2017, 9(4):320-324.
|
| [14] |
Association AD. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl.1):S65-S72.
|
| [15] |
Reis CE,Alvarez-Leite JI,Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index<35 kg/m2: a literature review[J]. Diabetes Technol Ther, 2012, 14(4):365-372.
|
| [16] |
Berry MA,Urrutia L,Lamoza P, et al. Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up[J]. Obesity Surgery, 2018, 28(3):1-7.
|
| [17] |
Park JY,Kim YJ. Efficacy of Laparoscopic Sleeve Gastrectomy in Mildly Obese Patients with Body Mass Index of 30-35 kg/m2[J]. Obesity Surgery, 2015, 25(8):1351-1357.
|
| [18] |
祝永刚, 张耐茹.胃转流术治疗2型糖尿病122例疗效分析[J].中华实用诊断与治疗杂志, 2013, 27(2):191-193.
|
| [19] |
Di J,Zhang H,Yu H, et al. Effect of Roux-en-Y Gastric Bypass on the Remission of Type 2 Diabetes Mellitus: A 3-Year Study in Chinese Patients with a BMI[J]. Surgery for Obesity & Related Diseases, 2016, 12(7):1357-1363.
|
| [20] |
Du X,Zhou HX,Zhang S Q, et al. A comparative study of the metabolic effects of LSG and LRYGB in chinese diabetes patients with BMI<35 kg/m2 [J]. Surgery for Obesity & Related Diseases, 2017, 13(2):189-197.
|
| [21] |
Spivak H,Abdelmelek MF,Beltran OR, et al. Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic roux- en-y gastric bypass in the united states[J]. Surgical endoscopy, 2012, 26(7):1909-1919.
|
| [22] |
Committee AI. Bariatric surgery in class I obesity (body mass index 30-35 kg/m2).[J]. Surg Obes Relat Dis, 2013, 9(1):e1-e10.
|
| [23] |
Celio AC,Pories WJ. A History of Bariatric Surgery: The Maturation of a Medical Discipline[J]. Surgical Clinics of North America, 2016, 96(4):655-667.
|
| [24] |
Angrisani L,Santonicola A,Iovino P, et al. Bariatric Surgery Worldwide 2013[J]. Obesity Surgery, 2015, 25(10):1822-1832.
|
| [25] |
Khorgami Z,Andalib A,Corcelles R, et al. A111 – Recent National Trends In The Surgical Treatment of Obesity: Sleeve Gastrectomy Dominates[J]. Surgery for Obesity & Related Diseases, 2015, 11(6):S6-S8.
|
| [26] |
Rao WS,Shan CX,Zhang W, et al. A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI≤35 kg/m2 undergoing Roux-en-Y gastric bypass[J]. World J Surg, 2015, 39(1):223-230.
|
| [27] |
Dixon JB,Hur KY,Lee WJ, et al. Gastric bypass in Type 2 diabetes with BMI<30: weight and weight loss have a major influence on outcomes[J]. Diabetic Medicine, 2013, 30(4):e127-e134.
|
| [28] |
Huang CK,Goel R,Tai CM, et al. Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy[J]. Surg Laparosc Endosc Percutan Tech, 2013, 23(6):481-485.
|
| [29] |
Lopeznava G,Galvão MP,Da BCI, et al. Endoscopic sleeve gastroplasty for the treatment of obesity[J]. Endoscopy, 2015, 47(5):449-452.
|
| [30] |
Sharaiha RZ,Kedia P,Kumta N, et al.Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population[J]. Endoscopy, 2015, 47(2):164-166.
|